Tiziana Life Sciences wins FDA approval to add patients to Multiple Sclerosis Expanded Access Program

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has been approved by the US Food and Drug Administration to expand patient enrollment in its...

Related Keywords

Gabriele Cerrone ,Tanuja Chitnis ,Tiziana Life Sciences Ltd ,Drug Administration ,Access Program ,Secondary Progressive Multiple Sclerosis ,Expanded Access ,Expanded Access Program ,